Actively Recruiting
Peridontal and Intestinal Microbiota in Patients With Gingival Scarring Pemphigoid
Led by Centre Hospitalier Universitaire de Nice · Updated on 2025-03-20
45
Participants Needed
3
Research Sites
107 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Patients suffering from Mucous Membrane Pemphigoid with desquamative gingivitis (MMPg) generally present a more degraded periodontal condition compared with controls. Bullous disease could represent a risk factor for plaque-induced periodontal disease, and vice versa. Indeed, the dysbiotic periodontal microbiota could aggravate the gingival damage specific to MMP, either directly by activating inflammatory pathways, or indirectly by degrading cellular and matrix components. On the other hand, areas of erosive gingiva generated by the autoimmune process could increase the virulent power of periodontal pathobionts, by representing accessible, nutrient-rich connective surfaces. Moreover, in recent years, bacterial studies based on a high-throughput metagenomic approach have suggested the existence of a relationship between the oral and intestinal microbiota in patients with degraded periodontal conditions and suffering from autoimmune inflammatory diseases (inflammatory bowel disease, acute graft-versus-host disease). This relationship can also be envisaged in MMPg patients who meet the conditions that allow this type of pathological process to occur: autoimmune disease; disruption of the gingival epithelial barrier in erosive gingival areas (increasing the risk of antigen exposure); large amounts of thick plaque; degraded periodontal condition with the presence of numerous periodontal pockets from which periodontopathogenic bacteria can translocate intra-tissularly and cause distant adverse consequences. The main aim of this observational, multicentre, case-control, matched study is to compare the composition of the periodontal microbiota between MMPg patients and control patients (arm 2 and arm 3). The secondary objectives are to compare the composition of periodontal and intestinal microbiota in cases and control patients (arm 2 and arm 3), to compare periodontal microbiota composition in cases and control patients (arm 2) according to periodontitis severity, and to compare gut microbiota composition between cases and control patients (arm 2 and arm3). To date, no such study exists.
CONDITIONS
Official Title
Peridontal and Intestinal Microbiota in Patients With Gingival Scarring Pemphigoid
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years or older
- Non-smokers for Arm 1
- Diagnosis of Mucous Membrane Pemphigoid with desquamative gingivitis (MMPg) and periodontitis for Arm 2
- Patients without MMPg but with periodontitis, matched to cases by age, gender, and severity of periodontitis
- Patients without MMPg and with healthy periodontal conditions, matched to cases by age and gender for Arm 3
You will not qualify if you...
- Antibiotic therapy or mechanical periodontal treatment within 3 months prior to the study
- Presence of other chronic general illnesses of immune or digestive origin
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Nice University Hospital
Nice, France, 06000
Actively Recruiting
2
Paris hospital Pitié Salpetrière (APHP)
Paris, France, 75013
Actively Recruiting
3
Paris hospital Bretonneau (APHP)
Paris, France, 75018
Actively Recruiting
Research Team
S
Sophie DRIDI, PUPH
CONTACT
R
rachida YATIMI
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here